Cas:1132-14-5 3,5-di-tert-butyl-1H-pyrazole manufacturer & supplier

Chemical Name:3,5-di-tert-butyl-1H-pyrazole

CAS.NO:1132-14-5

Synonyms:3,5-Di-t-butylpyrazole;1H-Pyrazole,3,5-bis(1,1-dimethylethyl);3,5-bis(tert-butyl)pyrazol;3,5-tBu2-pyrazole;(3,5-di-tert-butyl)pyrazole;3,5-di-tert-butyl-1H-pyrazole

Molecular Formula:C₁₁H₂₀N₂

Molecular Weight:180.29000

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:255.3ºC at 760mmHg

Density:0.927g/cm3

Index of Refraction:1.483

PSA:28.68000

Exact Mass:180.16300

LogP:3.00470

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,5-Di-t-butylpyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,5-di-tert-butyl-1H-pyrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,5-bis(tert-butyl)pyrazol Use and application,(3,5-di-tert-butyl)pyrazole technical grade,usp/ep/jp grade.

Related News: GSK picked McNamara after six months of “extensive search and selection process,” GSK said in its announcement Thursday. It ran the quest with help from two headhunters and evaluated “several external and internal candidates,” it said. 2,3-Bis-(difluoramino)-propyl-isocyanat manufacturers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. 5-methyl-3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,2,4-oxadiazole suppliers AstraZeneca acquired global rights to anifrolumab through an exclusive license and collaboration agreement with Medarex, Inc. in 2004. Medarex was acquired by Bristol-Myers Squibb in 2009. 3,5-Pyridinedicarboxylic acid,1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-,1,4-dioxaspiro[4.5]dec-2-ylmethyl ethyl ester vendor & factory.